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Introduction
In January 2012, a program was set up to rapidly screen
patients with undiagnosed muscle disorders who were
referred to a neuromuscular specialist in an adult hospi-
tal. A nurse was trained to do the DBS procedure as
part of a series of required laboratory tests. All indivi-
duals referred to a neuromuscular specialist, either
within the context of a neuromuscular clinic or an EMG
laboratory, were considered. Patients with an elevated
CPK, symptoms and signs indicative of a metabolic
myopathy or limb girdle myopathy or muscular dystro-
phy, and without an obvious diagnosis (myotonic dystro-
phy, dermatomyositis, oculopharyngeal muscular
dystrophy, FSH dystrophy) were tested on the initial
visit. Those with positive DBS testing had samples sent
to Duke University for genetic testing.
Results
117 patients have been tested to date (number will
increase by November 2012). Of these, 5 patients were
found to have significant abnormalities on DBS testing.
Genetic results are pending.
Discussion
This approach was designed to further define the clinical
phenotypes of patients with Pompe disease. A second
objective was to create a system in an adult setting
whereby DBS is used routinely, thereby increasing the abil-
ity to identify Pompe patients with previously undiagnosed
myopathies. The setup is user friendly, eliminates the need
for muscle biopsy in a percentage of patients, and can
easily be expanded to include patients referred to other
neuromuscular specialists in the hospital system, as well as
pulmonologists following patients with undiagnosed neu-
romuscular respiratory failure. Future plans include
expanding to include these other patient populations.
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